{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T04:36:17Z","timestamp":1790138177436,"version":"4.0.1"},"reference-count":31,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2008,6,1]],"date-time":"2008-06-01T00:00:00Z","timestamp":1212278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,6,1]],"date-time":"2008-06-01T00:00:00Z","timestamp":1212278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2008,6]]},"DOI":"10.1016\/j.nbd.2008.01.014","type":"journal-article","created":{"date-parts":[[2008,3,12]],"date-time":"2008-03-12T15:16:31Z","timestamp":1205334991000},"page":"293-302","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"title":["Tiagabine is neuroprotective in the N171-82Q and R6\/2 mouse models of Huntington's disease"],"prefix":"10.1016","volume":"30","author":[{"given":"Naoki","family":"Masuda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mali","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yideng","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenfei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher A.","family":"Ross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenzhen","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.nbd.2008.01.014_bb0005","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.nbd.2004.04.001","article-title":"A cell-based screen for drugs to treat Huntington's disease","volume":"16","author":"Aiken","year":"2004","journal-title":"Neurobiol. Dis."},{"issue":"6","key":"10.1016\/j.nbd.2008.01.014_bb0010","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1002\/ana.410380602","article-title":"Selective neurodegeneration in Huntington's disease","volume":"38","author":"Albin","year":"1995","journal-title":"Ann. Neurol."},{"issue":"4","key":"10.1016\/j.nbd.2008.01.014_bb0015","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/ana.410310412","article-title":"Preferential loss of striato-external pallidal projection neurons in presymptomatic Huntington's disease","volume":"31","author":"Albin","year":"1992","journal-title":"Ann. Neurol."},{"issue":"13","key":"10.1016\/j.nbd.2008.01.014_bb0020","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1021\/jm990513k","article-title":"Synthesis of novel gamma-aminobutyric acid (GABA) uptake inhibitors. 5.(1) Preparation and structure-activity studies of tricyclic analogues of known GABA uptake inhibitors","volume":"44","author":"Andersen","year":"2001","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.nbd.2008.01.014_bb0025","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1023\/A:1022393604014","article-title":"Novel mechanisms of action of three antiepileptic drugs, vigabatrin, tiagabine, and topiramate","volume":"28","author":"Angehagen","year":"2003","journal-title":"Neurochem. Res."},{"issue":"7010","key":"10.1016\/j.nbd.2008.01.014_bb0030","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/nature02998","article-title":"Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death","volume":"431","author":"Arrasate","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2008.01.014_bb0035","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.neuroimage.2005.01.039","article-title":"Magnetic resonance imaging at microscopic resolution reveals subtle morphological changes in a mouse model of dopaminergic hyperfunction","volume":"26","author":"Cyr","year":"2005","journal-title":"NeuroImage"},{"issue":"5334","key":"10.1016\/j.nbd.2008.01.014_bb0040","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1126\/science.277.5334.1990","article-title":"Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain","volume":"277","author":"DiFiglia","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.nbd.2008.01.014_bb0045","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1126\/science.277.5334.1990","article-title":"Aggregation of huntingtin in neuronal intracellular inclusions and dystrophic neuritis in brain","volume":"277","author":"DiFiglia","year":"1997","journal-title":"Science"},{"issue":"43","key":"10.1016\/j.nbd.2008.01.014_bb0050","doi-asserted-by":"crossref","first-page":"17204","DOI":"10.1073\/pnas.0708285104","article-title":"Therapeutic silencing of mutant huntingtin with siRNA attenuates striatal and cortical neuropathology and behavioral deficits","volume":"104","author":"DiFiglia","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2008.01.014_bb0055","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1073\/pnas.0536856100","article-title":"Dietary restriction normalizes glucose metabolism and BDNF levels, slows disease progression, and increases survival in huntingtin mutant mice","volume":"100","author":"Duan","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"6","key":"10.1016\/j.nbd.2008.01.014_bb0060","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1111\/j.1528-1157.1995.tb02575.x","article-title":"Pharmacokinetics of tiagabine, a gamma-aminobutyric acid-uptake inhibitor, in healthy subjects after single and multiple doses","volume":"36","author":"Gustavson","year":"1995","journal-title":"Epilepsia"},{"issue":"3","key":"10.1016\/j.nbd.2008.01.014_bb0065","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1602\/neurorx.1.3.298","article-title":"Translating therapies for Huntington's disease from genetic animal models to clinical trials","volume":"1","author":"Hersch","year":"2004","journal-title":"NeuroRx"},{"issue":"12","key":"10.1016\/j.nbd.2008.01.014_bb0070","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.2174\/1381612003399608","article-title":"GABA uptake inhibitors. Design, molecular pharmacology and therapeutic aspects","volume":"6","author":"Krogsgaard-Larsen","year":"2000","journal-title":"Curr. Pharm. Des."},{"issue":"10","key":"10.1016\/j.nbd.2008.01.014_bb0075","first-page":"958","article-title":"Huntingtin and the molecular pathogenesis of Huntington's disease","volume":"5","author":"Landles","year":"2004","journal-title":"Fourth in molecular medicine review series. EMBO. Rep."},{"issue":"21","key":"10.1016\/j.nbd.2008.01.014_bb0080","doi-asserted-by":"crossref","first-page":"8473","DOI":"10.1523\/JNEUROSCI.21-21-08473.2001","article-title":"Huntingtin aggregate-associated axonal degeneration is an early pathological event in Huntington's disease mice","volume":"21","author":"Li","year":"2001","journal-title":"J. Neurosci."},{"issue":"11","key":"10.1016\/j.nbd.2008.01.014_bb0085","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1345\/aph.18053","article-title":"Tiagabine: a novel antiepileptic drug","volume":"32","author":"Luer","year":"1998","journal-title":"Ann. Pharmacother."},{"issue":"5","key":"10.1016\/j.nbd.2008.01.014_bb0090","doi-asserted-by":"crossref","first-page":"513","DOI":"10.33549\/physiolres.931049","article-title":"Integrative hypothesis for Huntington's disease: a brief review on experimental evidence","volume":"56","author":"Perez-De La Cruz","year":"2007","journal-title":"Physiol. Res. Dec,"},{"issue":"1","key":"10.1016\/j.nbd.2008.01.014_bb0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/exnr.1998.7006","article-title":"Recent advances on the pathogenesis of Huntington's disease","volume":"157","author":"Petersen","year":"1999","journal-title":"Exp. Neurol."},{"issue":"15","key":"10.1016\/j.nbd.2008.01.014_bb0100","doi-asserted-by":"crossref","first-page":"5733","DOI":"10.1073\/pnas.85.15.5733","article-title":"Differential loss of striatal projection neurons in Huntington disease","volume":"85","author":"Reiner","year":"1988","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.nbd.2008.01.014_bb0105","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0304-3940(91)90448-3","article-title":"Heterogeneous dopamine receptor changes in early and late Huntington's disease","volume":"132","author":"Richfield","year":"1991","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.nbd.2008.01.014_bb0110","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1038\/nm1066","article-title":"Protein aggregation and neurodegenerative disease","volume":"10","author":"Ross","year":"2004","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.nbd.2008.01.014_bb0115","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1517\/14656566.2.1.179","article-title":"Pharmacology and clinical experience with tiagabine","volume":"2","author":"Schachter","year":"2001","journal-title":"Expert. Opin. Pharmacother."},{"issue":"3","key":"10.1016\/j.nbd.2008.01.014_bb0120","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/hmg\/8.3.397","article-title":"Intranuclear inclusions and neuritic aggregates in transgenic mice expressing a mutant N-terminal fragment of huntingtin","author":"Schilling","year":"1999","journal-title":"Hum. Mol. Genet."},{"issue":"10","key":"10.1016\/j.nbd.2008.01.014_bb0125","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.2174\/0929867003374363","article-title":"The GABA transporter and its inhibitors","volume":"7","author":"Soudijn","year":"2000","journal-title":"Curr. Med. Chem."},{"issue":"1","key":"10.1016\/j.nbd.2008.01.014_bb0130","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.pharmthera.2006.07.005","article-title":"Novel anticonvulsant drugs","volume":"113","author":"Stefan","year":"2007","journal-title":"Pharmacol. Ther."},{"issue":"5","key":"10.1016\/j.nbd.2008.01.014_bb0135","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/00005072-199805000-00001","article-title":"Huntington disease","volume":"57","author":"Vonsattel","year":"1998","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"9\u201310","key":"10.1016\/j.nbd.2008.01.014_bb0140","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1515\/BC.2000.114","article-title":"Protein aggregation and pathogenesis of Huntington's disease: mechanisms and correlations","volume":"381","author":"Wanker","year":"2000","journal-title":"Biol. Chem."},{"issue":"2","key":"10.1016\/j.nbd.2008.01.014_bb0145","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.nbd.2005.03.026","article-title":"Compounds blocking mutant huntingtin toxicity identified using a Huntington's disease neuronal cell model","volume":"20","author":"Wang","year":"2005","journal-title":"Neurobiol. Dis."},{"issue":"6","key":"10.1016\/j.nbd.2008.01.014_bb0150","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1523\/JNEUROSCI.23-06-02193.2003","article-title":"Mutant huntingtin causes context-dependent neurodegeneration in mice with Huntington's disease","volume":"23","author":"Yu","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2008.01.014_bb0155","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jchromb.2005.01.027","article-title":"Specific method for determination of gefitinib in human plasma, mouse plasma and tissues using high performance liquid chromatography coupled to tandem mass spectrometry","volume":"819","author":"Zhao","year":"2005","journal-title":"J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996108000235?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996108000235?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T05:02:01Z","timestamp":1760850121000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996108000235"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,6]]}},"alternative-id":["S0969996108000235"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2008.01.014","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2008,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tiagabine is neuroprotective in the N171-82Q and R6\/2 mouse models of Huntington's disease","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2008.01.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}